P1157 IMPACT OF BASELINE VARIABLES ON RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON a-2a AND RIBAVIRIN IN PATIENTS WITH HIV/HCV GENOTYPE-1 COINFECTION IN A PHASE III TRIAL.

Authors :: Tural, C.
Rockstroh, J.K.
Nelson, M.
Bhagani, S.
Ingiliz, P.
Soriano, V.
Núñez, M.
Valantin, M.-A.
Valdez Madruga, J.
Rauch, A.
Furtado, J.
Battegay, M.
Stern, J.O.
Quinson, A.-M.
Böcher, W.
Vinisko, R.
Manero, M.
Dieterich, D.
Source :: Journal of Hepatology. Apr2014 Supplement, Vol. 60, pS469-S469. 1p.
Publication Year :: 2014

Subjects :: *INTERFERONS
*RIBAVIRIN
*OLIGOPEPTIDES
*HEPATITIS C
*HEPATITIS C treatment
*PATIENTS
*THERAPEUTICS

Full Text Access

Tools